3-D Matrix Ltd
3-D Matrix, Ltd. developing, manufacturing, and selling self-assembling peptide technology in Japan and internationally. It offers PuraMatrix, a self-assembling peptide hydrogel for use in the regenerative medicine, cell therapy, drug delivery systems, and other uses in various fields. The company was incorporated in 2004 and is based in Tokyo, Japan
3-D Matrix Ltd (DMTRF) - Net Assets
Latest net assets as of October 2025: $3.95 Billion USD
Based on the latest financial reports, 3-D Matrix Ltd (DMTRF) has net assets worth $3.95 Billion USD as of October 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($6.80 Billion) and total liabilities ($2.84 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $3.95 Billion |
| % of Total Assets | 58.16% |
| Annual Growth Rate | 4.8% |
| 5-Year Change | 33.52% |
| 10-Year Change | -43.69% |
| Growth Volatility | 158.27 |
3-D Matrix Ltd - Net Assets Trend (2011–2025)
This chart illustrates how 3-D Matrix Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for 3-D Matrix Ltd (2011–2025)
The table below shows the annual net assets of 3-D Matrix Ltd from 2011 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-04-30 | $2.22 Billion | +527.27% |
| 2024-04-30 | $353.31 Million | -32.67% |
| 2023-04-30 | $524.77 Million | -64.00% |
| 2022-04-30 | $1.46 Billion | -12.18% |
| 2021-04-30 | $1.66 Billion | +250.90% |
| 2020-04-30 | $473.02 Million | -68.74% |
| 2019-04-30 | $1.51 Billion | -31.29% |
| 2018-04-30 | $2.20 Billion | -15.55% |
| 2017-04-30 | $2.61 Billion | -33.75% |
| 2016-04-30 | $3.94 Billion | -38.33% |
| 2015-04-30 | $6.38 Billion | +103.66% |
| 2014-04-30 | $3.13 Billion | +51.69% |
| 2013-04-30 | $2.07 Billion | -28.47% |
| 2012-04-30 | $2.89 Billion | +151.14% |
| 2011-04-30 | $1.15 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to 3-D Matrix Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 2466900000000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (April 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $15.49 Billion | 698.94% |
| Other Components | $12.99 Billion | 586.22% |
| Total Equity | $2.22 Billion | 100.00% |
3-D Matrix Ltd Competitors by Market Cap
The table below lists competitors of 3-D Matrix Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Lhyfe SA
PINK:LHYFF
|
$77.31 Million |
|
Pekat Group Bhd
KLSE:0233
|
$77.34 Million |
|
Loop Telecommunication International Inc
TW:3025
|
$77.34 Million |
|
Landmark Cars Limited
NSE:LANDMARK
|
$77.39 Million |
|
Power Metals Corp
OTCQB:PWRMF
|
$77.30 Million |
|
TUL Corporation
TWO:6150
|
$77.27 Million |
|
COWINTECH Co. Ltd
KQ:282880
|
$77.27 Million |
|
Shelf Drilling Ltd
PINK:SHLLF
|
$77.26 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in 3-D Matrix Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 353,307,000 to 2,216,194,000, a change of 1,862,887,000 (527.3%).
- Net loss of 2,501,245,000 reduced equity.
- New share issuances of 2,616,470,000 increased equity.
- Other comprehensive income increased equity by 3,509,000,000.
- Other factors decreased equity by 1,761,338,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-2.50 Billion | -112.86% |
| Share Issuances | $2.62 Billion | +118.06% |
| Other Comprehensive Income | $3.51 Billion | +158.33% |
| Other Changes | $-1.76 Billion | -79.48% |
| Total Change | $- | 527.27% |
Book Value vs Market Value Analysis
This analysis compares 3-D Matrix Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.03x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2011-04-30 | $79.27 | $0.69 | x |
| 2012-04-30 | $161.52 | $0.69 | x |
| 2013-04-30 | $111.13 | $0.69 | x |
| 2014-04-30 | $159.75 | $0.69 | x |
| 2015-04-30 | $303.54 | $0.69 | x |
| 2016-04-30 | $183.21 | $0.69 | x |
| 2017-04-30 | $120.99 | $0.69 | x |
| 2018-04-30 | $95.88 | $0.69 | x |
| 2019-04-30 | $57.69 | $0.69 | x |
| 2020-04-30 | $15.79 | $0.69 | x |
| 2021-04-30 | $40.95 | $0.69 | x |
| 2022-04-30 | $28.62 | $0.69 | x |
| 2023-04-30 | $8.72 | $0.69 | x |
| 2024-04-30 | $4.82 | $0.69 | x |
| 2025-04-30 | $22.33 | $0.69 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently 3-D Matrix Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -112.86%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -36.07%
- • Asset Turnover: 1.06x
- • Equity Multiplier: 2.94x
- Recent ROE (-112.86%) is above the historical average (-139.31%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2011 | -46.43% | -337.26% | 0.13x | 1.04x | $-648.95 Million |
| 2012 | 10.69% | 27.87% | 0.36x | 1.06x | $19.82 Million |
| 2013 | -47.36% | -3056.04% | 0.01x | 1.46x | $-1.18 Billion |
| 2014 | -48.68% | -1423.45% | 0.03x | 1.32x | $-1.84 Billion |
| 2015 | -31.26% | -1999.44% | 0.01x | 1.07x | $-2.63 Billion |
| 2016 | -62.49% | -1733.94% | 0.03x | 1.13x | $-2.85 Billion |
| 2017 | -53.41% | -226.12% | 0.18x | 1.31x | $-1.65 Billion |
| 2018 | -84.76% | -816.31% | 0.07x | 1.42x | $-2.09 Billion |
| 2019 | -168.84% | -776.82% | 0.08x | 2.70x | $-2.71 Billion |
| 2020 | -654.55% | -460.45% | 0.22x | 6.59x | $-3.14 Billion |
| 2021 | -121.25% | -196.47% | 0.29x | 2.11x | $-2.18 Billion |
| 2022 | -129.98% | -125.79% | 0.27x | 3.85x | $-2.04 Billion |
| 2023 | -466.10% | -105.70% | 0.40x | 11.10x | $-2.50 Billion |
| 2024 | -72.32% | -5.57% | 0.78x | 16.66x | $-290.84 Million |
| 2025 | -112.86% | -36.07% | 1.06x | 2.94x | $-2.72 Billion |
Industry Comparison
This section compares 3-D Matrix Ltd's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| 3-D Matrix Ltd (DMTRF) | $3.95 Billion | -46.43% | 0.72x | $77.30 Million |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |